Citation 76877

KREBS,HC: SOLLINGER,P:. (1996). TRITERPENE GLYCOSIDES FROM POLYGALA KLOTZSCHII.. 51(6)

Citation Details

TitleTRITERPENE GLYCOSIDES FROM POLYGALA KLOTZSCHII.
AuthorsKREBS,HC: SOLLINGER,P:
Year1996
Volume51
Issue6

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Polygala klotzschii (POLYGALACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
MEDICAGENIC ACID,29-O-(BETA-D-GLUCOFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(ALPHA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL:
None
2
CELL PROLIFERATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDICAGENIC ACID,29-O-(BETA-D-GLUCOFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(ALPHA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL:MEDICAGENIC ACID,28-O-(ALPHA-L-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(BETA-D-XYLOPFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL-16-ALPHA-HYDROXY:
ACTIVE
3
CELL PROLIFERATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDICAGENIC ACID,29-O-(BETA-D-GLUCOFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(ALPHA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL:MEDICAGENIC ACID,28-O-(ALPHA-L-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(BETA-D-XYLOPFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL-16-ALPHA-HYDROXY:
ACTIVE
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MEDICAGENIC ACID,29-O-(BETA-D-GLUCOFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(ALPHA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL:MEDICAGENIC ACID,28-O-(ALPHA-L-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(BETA-D-XYLOPFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL-16-ALPHA-HYDROXY:
ACTIVE
5
CELL PROLIFERATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDICAGENIC ACID,29-O-(BETA-D-GLUCOFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(ALPHA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL:MEDICAGENIC ACID,28-O-(ALPHA-L-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(BETA-D-XYLOPFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL-16-ALPHA-HYDROXY:
ACTIVE
6
CELL PROLIFERATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDICAGENIC ACID,29-O-(BETA-D-GLUCOFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(ALPHA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL:MEDICAGENIC ACID,28-O-(ALPHA-L-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(BETA-D-XYLOPFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL-16-ALPHA-HYDROXY:
ACTIVE
7Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
MEDICAGENIC ACID,28-O-(ALPHA-L-RHAMNOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL(1-4)-(BETA-D-XYLOPFURANOSYL(1-2)-BETA-D-XYLOPYRANOSYL(1-3))-BETA-D-XYLOPYRANOSYL)-3-O-BETA-D-GLUCOPYRANOSYL-16-ALPHA-HYDROXY:
None
Show SPARQL Queries (1)